From population to public institutions: what needs to be changed to benefit from the full value of vaccination
| Autor: | Sibilia Quilici, Marina Panfilo, Thomas D. Szucs |
|---|---|
| Přispěvatelé: | Sanofi Pasteur MSD |
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Journal of Market Access & Health Policy; Vol 3 (2015) Journal of Market Access & Health Policy |
| Popis: | The poor perception of the benefits of vaccines, and their subsequent underuse, can result in substantial economic, societal, and political burden. Adequate support and communication from health authorities and governments is essential to promote the benefits of vaccination and reduce the risk of infectious diseases outbreaks. Cost-containment policies in the vaccine procurement processes could also be a threat to the long-term sustainability of the vaccine industry and manufacturing sites in Europe. Biologicals, such as vaccines, are highly technical and complex products to manufacture and only a few industries are engaged in this activity. Developing incentives to encourage vaccine manufacturers and identifying means of taking into consideration the specificities of vaccines in economic evaluations could allow the full value of vaccination to be appreciated. In conclusion, governments, international agencies, and other stakeholders have an important role to play to help society regain confidence in vaccination and ensure that the benefits of vaccination programmes are fully recognised and valued. Keywords: vaccination; outbreaks; value; vaccine industry; economic evaluation; vaccines complexity (Published: 12 August 2015) Citation: Journal of Market Access & Health Policy 2015, 3: 26965 - http://dx.doi.org/10.3402/jmahp.v3.26965 (page number not for citation |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|